-
Entity
-
Individual
-
Location
-
Damonmill Square, Suite 6 A, Concord, Massachusetts
-
Summary
-
The estimated net worth of Daniel E. Geffken is at least $138K dollars as of May 20, 2024. Daniel E. Geffken is the Chief Financial Officer of PHOENIX BIOTECH ACQUISITION CORP. and owns shares of CERO THERAPEUTICS HOLDINGS, INC. (CERO) stock worth about $100K. Daniel E. Geffken is the INTERIM CFO of Eloxx Pharmaceuticals, Inc. and owns shares of Eloxx Pharmaceuticals, Inc. (ELOX) stock worth about $36K. Daniel E. Geffken is the Director of WINDTREE THERAPEUTICS INC /DE/ and owns shares of WINDTREE THERAPEUTICS INC /DE/ (WINT) stock worth about $2.22K.